Just two weeks after approving Pfizer Bio-n-tech’s coronavirus vaccine another developer gets the go signal from the food and drug administration for emergency use.
Our Carolyn Bonquin gives us the details on Oxford-Astrazeneca’s vaccine.
ADVERTISEMENT
